11.06.2012 - German healthcare conglomerate Fresenius on Monday raised its 2012 profit outlook for a second time this year as its injectable generic drugs unit Kabi continues to benefit from...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)